57
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Delivery of sodium morrhuate to hemangioma endothelial cells using immunoliposomes conjugated with anti-VEGFR2/KDR antibody

, , , , &
Pages 6963-6972 | Published online: 19 Sep 2017

References

  • SmolinskiKNYanACHemangiomas of infancy: clinical and biological characteristicsClin Pediatr (Phila)200544974776616327961
  • BuckmillerLMRichterGTSuenJYDiagnosis and management of hemangiomas and vascular malformations of the head and neckOral Dis201016540541820233314
  • PrzewratilPSitkiewiczAWykaKAndrzejewskaESerum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations – preliminary reportPediatr Dermatol200926439940419689513
  • MullikenJBGlowackiJHemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristicsPlast Reconstr Surg19826934124227063565
  • Hemangioma Investigator GroupHaggstromANDroletBABaselgaEProspective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristicsJ Pediatr2007150329129417307549
  • HeWGuALShangJLComparison of the clinical therapeutic effects between local injection of pingyangmycin and sodium morrhuate on oral and maxillofacial venous malformationZhonghua Kou Qiang Yi Xue Za Zhi2007425308309 Chinese17686287
  • ShouBQShouWDMengZYYangZZhangSLThe effect of pinyangmycin, dexamethasonum and sodium morrhuate injected concomitantly to treat cavernous hemangiomaShanghai Kou Qiang Yi Xue2003121911 Chinese14661451
  • ShouBQYangZMengZYHuangDBZhengHDingGQClinical summary of relatively large dose of sodium morrhuate injection for the treatment of maxillofacial cavernous hemangioma: a report of 764 casesShanghai Kou Qiang Yi Xue1996527173 Chinese15160026
  • ZhouKLiangCYangKWangLA randomized controlled study on the efficacy of modified sclerotherapy in treating angioma of ear, nose and throatLin Chuang Er Bi Yan Hou Ke Za Zhi20021612681683 Chinese12669445
  • MorganJFSchowCEJrUse of sodium morrhuate in the management of hemangiomasJ Oral Surg19743253633664524274
  • GuoJWuHChanges of cultured human vein endothelial cells (HVEC) in the presence of therapeutic agents of cavernous hemangiomaHua Xi Kou Qiang Yi Xue Za Zhi2000185310313 Chinese12539648
  • FuJLiuZChenXAcral necrosis induced by sodium morrhuate sclerotherapy in infantile haemangioma: a case reportJ Hand Surg Eur Vol201742220620726647397
  • HeXLiuYLiKYangAWangRLiuSSildenafil suppresses the proliferation and enhances the apoptosis of hemangioma endothelial cellsExp Ther Med20171362645265028587325
  • WnękAAndrzejewskaEKobosJTaranKPrzewratilPMolecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatmentImmunol Lett2017185273128279700
  • TuJBWangZHSongYThe effect of lipo-sodium morrhuate on human hemangioma endothelial cellsChina J Oral Maxillofac Surg200756445450 Chinese
  • TakahashiKMullikenJBKozakewichHPRogersRAFolkmanJEzekowitzRACellular markers that distinguish the phases of hemangioma during infancy and childhoodJ Chin Invest199493623572364
  • DarrowDHGreeneAKManciniAJNooperAJDiagnosis and management of infantile hemangiomaPediatrics20151364e1060e110426416931
  • FinnMCGlowackiJMullikenJBCongenital vascular lesions: clinical application of a new classificationJ Pediatr Surg19831868949006663421
  • RangwalaSWysongATollefsonMMKhuuPBenjaminLTBrucknerALRapidly involuting congenital hemangioma associated with profound, transient thrombocytopeniaPediatr Dermatol201431340240422937785
  • LyonsLLNorthPEMac-Moune LaiFStolerMHFolpeALWeissSWKaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangiomaAm J Surg Pathol200428555956815105642
  • ZhangWZhangXRenXEffects of intervention embolization therapy and intratumor injection with hardener on head and neck gigantic hemangiomaLin Chuang Er Bi Yan Hou Ke Za Zhi2005193117118 Chinese15844611
  • WangZLiJXuXDuanXCaoGUrea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatmentWorld J Surg Oncol20131130024266957
  • LiYYuanJYangQImmunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanomaInt J Nanomedicine201495683570025506218
  • SharmaGAnabousiSEhrhardtCRavi KumarMNLiposomes as targeted drug delivery systems in the treatment of breast cancerJ Drug Target200614530131016882550
  • HansenCBKaoGYMoaseEHZalipskySAllenTMAttachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling proceduresBiochim Biophys Acta1995123921331447488618
  • PanXWuGYangWBarthRFTjarksWLeeRJSynthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFRBioconjug Chem200718110110817226962
  • FuYYangZGZhaoLYAngiogenesis characteristics of infantile hemangioma and feasibility observation of transplantation model of human hemangioma on miceEur Rev Med Pharmacol Sci20172161276128028387902
  • NeufeldGCohenTGengrinovitchSPoltorakZVascular endothelial growth factor (VEGF) and its receptorsFASEB J19991319229872925
  • JoplingHMOdellAFPellet-ManyCEndosome-to-plasma membrane recycling of VEGFR2 receptor tyrosine kinase regulates endothelial function and blood vessel formationCells20143236338524785348
  • QiuMKWangSQPanCROCK inhibition as a potential therapeutic target involved in apoptosis in hemangiomaOncol Rep20173752987299328339093
  • ElmoreSApoptosis: a review of programmed cell deathToxicol Pathol200735449551617562483